06 November 2013 11:26 [Source: ICIS news]
LONDON (ICIS)--Solvay will build and operate a large-scale alkoxylation unit in Pasadena, Texas, at an integrated industrial facility of LyondellBasell's Equistar Chemicals affiliate, in order to serve a growing North American market, the Belgium-based producer said on Wednesday.
Solvay will invest nearly €40m ($54m) into the unit, which is expected to be operational in 2015.
Equistar will supply the ethylene oxide raw material to the facility, the company added.
Capacity details of the project were not disclosed.
Through the alkoxylation process, key monomers are produced that serve downstream surfactant development and manufacturing.
"This is the latest in a series of strategic investments we have made to deploy capacity and product development assets to serve our customers in dynamic market segments," said Emmanuel Butstraen, president of Solvay Novecare.
"Spurred by a rebounding housing market and a dynamic manufacturing sector, the new facility will enable us to help our North America customers meet growing business opportunities in many markets," he added.
Pat Quarles, LyondellBasell senior vice president of intermediates and derivatives, said: "Co-locating the Solvay Novecare facility at our Bayport site and linking to our ethylene oxide unit by pipeline offers new opportunities and benefits for each of our companies to grow our businesses."
The investment follows Solvay's announcement in April this year that it will build an on-pipe alkoxylation facility in Singapore.
($1 = €0.74)
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections